Secretome, surfome and immunome: emerging approaches for the discovery of new vaccine candidates against bacterial infections

World Journal of Microbiology and Biotechnology

Volumn 32, Issue 9, 2016, Pages

  Dwivedi, Pratistha ^a   Alam, Syed Imteyaz ^b   Tomar, Rajesh Singh ^a  

^a AMITY UNIVERSITY MADHYA PRADESH   (India)

^b DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

Exoproteome; Immunoproteomics; Surface proteome; Vaccine

Indexed keywords

ANTIBODIES; ANTIGENS; BACTERIA; MOLECULAR BIOLOGY; PATHOGENS; PROTEINS;

ADVANCED STRUCTURE; ANALYSIS STRATEGIES; BACTERIAL INFECTIONS; BACTERIAL SURFACES; EXOPROTEOME; FUNCTIONAL GENOMICS; IDENTIFICATION OF PROTEINS; IMMUNOPROTEOMICS;

VACCINES;

BACTERIAL ANTIGEN; BACTERIAL VACCINE;

BACTERIAL INFECTIONS; BIOLOGY; DRUG DEVELOPMENT; HUMAN; IMMUNOLOGY; PROCEDURES; PROTEOMICS;

ANTIGENS, BACTERIAL; BACTERIAL INFECTIONS; BACTERIAL VACCINES; COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; HUMANS; PROTEOMICS;

EID: 84979692019     PISSN: 09593993     EISSN: 15730972     Source Type: Journal    
DOI: 10.1007/s11274-016-2107-3     Document Type: Review

References (60)

1. Adamczyk-Poplawska M, Markowicz S, Jagusztyn-Krynicka EK (2011) Proteomics for development of vaccine. J Proteom 74:2596–2616
2. Alam SI, Bansod S, Singh L (2008) Immunization against Clostridium perfringens cells elicits protection against Clostridium tetani in mouse model: identification of cross-reactive proteins using proteomic methodologies. BMC Microbiol 8:194
3. Alam SI, Bansod S, Kumar RB, Sengupta N, Singh L (2009) Differential proteomic analysis of Clostridium perfringens ATCC13124; identification of dominant, surface and structure associated proteins. BMC Microbiol 9:162
4. Ariel N, Zvi A, Makarova KS, Chitlaru T, Elhanany E, Velan B, Cohen S, Friedlander AM, Shafferman A (2003) Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens. Infect Immun 71(8):4563–4579
5. Backert S, Kwok T, Schmid M, Selbach M, Moese S, Peek RM Jr, König W, Meyer TF, Jungblut PR (2005) Subproteomes of soluble and structure-bound Helicobacter pylori proteins analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 5:1331–1345
6. Boetzkes A, Felkel KW, Zeiser J, Jochim N, Just I, Pich A (2012) Secretome analysis of Clostridium difficile strains. Arch Microbiol 194:675–687
7. Bøhle LA, Riaz T, Egge-Jacobsen W, Skaugen M, Busk ØL, Eijsink VG, Mathiesen G (2011) Identification of surface proteins in Enterococcus faecalis V583. BMC Genom 12:135
8. Choi CW, Lee YG, Kwon SO, Kim HY, Lee JC, Chung YH, Yun CY, Kim SI (2012) Analysis of Streptococcus pneumoniae secreted antigens by immuno-proteomic approach. Diagn Microbiol Infect Dis 72:318–327
9. Connolly JP, Comerci D, Alefantis TG, Walz A, Quan M, Chafin R, Grewal P, Mujer CV, Ugalde RA, DelVecchio VG (2006) Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development. Proteomics 6(13):3767–3780
10. Cordwell SJ, Larsen MR, Cole RT, Walsh BJ (2002) Comparative proteomics of Staphylococcus aureus and the response of methicillin-resistant and methicillin-sensitive strains to Triton X-100. Microbiology 148:2765–2781
11. DelVecchio VG, Sabato MA, Trichilo J, Dake C, Grewal P, Alefantis T (2010) Proteomics for the development of vaccines and therapeutics. Crit Rev Immunol 30:239–254
12. Diniz CG, Farias LM, Carvalho MA, Rocha ER, Smith CJ (2004) Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant. J Antimicrob Chemother 54:100–108
13. Doro F, Liberatori S, Rodríguez-Ortega MJ, Rinaudo CD, Rosini R, Mora M, Scarselli M, Altindis E, D’Aurizio R, Stella M, Margarit I, Maione D, Telford JL, Norais N, Grandi G (2009) Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1. Mol Cell Proteom 8:1728–1737
14. Dove A (1999) Proteomics: translating genomics into products? Nat Biotechnol 17:233–236
15. Dwivedi P, Alam SI, Kumar O, Kumar RB (2015a) Lipoproteins from Clostridium perfringens and their protective efficacy in mouse model. Infect Genet Evol 34:434–443
16. Dwivedi P, Alam SI, Kumar O, Kumar RB (2015b) Comparative analysis of extractable proteins from Clostridium perfringens type A and type C strains showing varying degree of virulence. Anaerobe 35(Pt B):77–91
17. Ebanks RO, Goguen M, McKinnon S, Pinto DM, Ross NW (2005) Identification of the major outer membrane proteins of Aeromonas salmonicida. Dis Aquat Organ 68:29–38
18. García-Angulo VA, Kalita A, Kalita M, Lozano L, Torres AG (2014) Comparative genomics and immunoinformatics approach for the identification of vaccine candidates for enterohemorrhagic Escherichia coli O157:H7. Infect Immun 82(5):2016–2026
19. Gomez G, Pei J, Mwangi W, Adams LG, Rice-Ficht A, Ficht TA (2013) Immunogenic and invasive properties of Brucella melitensis 16 M outer membrane protein vaccine candidates identified via a reverse vaccinology approach. PLoS One 8(3):e59751
20. Grandi G (2001) Antibacterial vaccine design using genomics and proteomics. Trends Biotechnol 19:181–188
21. He Y, Xiang Z, Mobley HL (2010) Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development. J Biomed Biotechnol 2010:297505
22. Hsu CA, Lin WR, Li JC, Liu YL, Tseng YT, Chang CM, Lee YS, Yang CY (2008) Immunoproteomic identification of the hypothetical protein NMB1468 as a novel lipoprotein ubiquitous in Neisseria meningitidis with vaccine potential. Proteomics 8(10):2115–2125
23. Huang CM, Elmets CA, Tang DC, Li F, Yusuf N (2004) Proteomics reveals that proteins expressed during the early stage of Bacillus anthracis infection are potential targets for the development of vaccines and drugs. Genom Proteoms Bioinform 2:143–151
24. Jennison AV, Raqib R, Verma NK (2006) Immunoproteome analysis of soluble and membrane proteins of Shigella flexneri 2457T. World J Gastroenterol 12(41):6683–6688
25. Krasteva I, Liljander A, Fischer A, Smith DG, Inglis NF, Scacchia M, Pini A, Jores J, Sacchini F (2014) Characterization of the in vitro core surface proteome of Mycoplasma mycoides subsp. mycoides, the causative agent of contagious bovine pleuropneumonia. Vet Microbiol 168(1):116–123
26. Li H, Ye MZ, Peng B, Wu HK, Xu CX, Xiong XP, Wang C, Wang SY, Peng XX (2010) Immunoproteomic identification of polyvalent vaccine candidates from Vibrio parahaemolyticus outer membrane proteins. J Proteome Res 9(5):2573–2583
27. Ling E, Feldman G, Portnoi M, Dagan R, Overweg K, Mulholland F, Chalifa-Caspi V, Wells J, Mizrachi-Nebenzahl Y (2004) Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clin Exp Immunol 138(2):290–298
28. Liu G, Zhang W, Lu C (2013) Identification of immunoreactive proteins of Streptococcus agalactiae isolated from cultured tilapia in China. Pathog Dis 69(3):223–231
29. Mariappan V, Vellasamy KM, Thimma JS, Hashim OH, Vadivelu J (2010) Identification of immunogenic proteins from Burkholderia cepacia secretome using proteomic analysis. Vaccine 28(5):1318–1324
30. Mattow J, Schaible UE, Schmidt F, Hagens K, Siejak F, Brestrich G, Haeselbarth G, Müller EC, Jungblut PR, Kaufmann SH (2003) Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen. Electrophoresis 24:3405–3420
31. McNamara M, Tzeng SC, Maier C, Zhang L, Bermudez LE (2012) Surface proteome of “Mycobacterium avium subsp. hominissuis” during the early stages of macrophage infection. Infect Immun 80(5):1868–1880
32. Mizrachi Nebenzahl Y, Bernstein A, Portnoi M, Shagan M, Rom S, Porgador A, Dagan R (2007) Streptococcus pneumoniae surface-exposed glutamyl trna synthetase, a putative adhesin, is able to induce a partially protective immune response in mice. J Infect Dis 196:945–953
33. Molestina RE, Klein JB, Miller RD, Pierce WH, Ramirez JA, Summersgill JT (2002) Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells. Infect Immun 70:2976–2981
34. Molloy MP, Herbert BR, Slade MB, Rabilloud T, Nouwens AS, Williams KL, Gooley AA (2000) Proteomic analysis of the Escherichia coli outer membrane. Eur J Biochem 267:2871–2881
35. Morsczeck C, Prokhorova T, Sigh J, Pfeiffer M, Bille-Nielsen M, Petersen J, Boysen A, Kofoed T, Frimodt-Møller N, Nyborg-Nielsen P, Schrotz-King P (2008) Streptococcus pneumoniae: proteomics of surface proteins for vaccine development. Clin Microbiol Infect 14:74–81
36. Naz A, Awan FM, Obaid A, Muhammad SA, Paracha RZ, Ahmad J, Ali A (2015) Identification of putative vaccine candidates against Helicobacter pylori exploiting exoproteome and secretome: a reverse vaccinology based approach. Infect Genet Evol 32:280–291
37. Pacheco LG, Slade SE, Seyffert N, Santos AR, Castro TL, Silva WM, Santos AV, Santos SG, Farias LM, Carvalho MA, Pimenta AM, Meyer R, Silva A, Scrivens JH, Oliveira SC, Miyoshi A, Dowson CG, Azevedo VA (2011) Combined approach for comparative exoproteome analysis of Corynebacterium pseudotuberculosis. BMC Microbiol 11(1):12
38. Pang HY, Li Y, Wu ZH, Jian JC, Lu YS, Cai SH (2010) Immunoproteomic analysis and identification of novel immunogenic proteins from Vibrio harveyi. J Appl Microbiol 109(5):1800–1809
39. Pellon A, Ramirez-Garcia A, Buldain I, Antoran A, Rementeria A, Hernando FL (2016) Immunoproteomics-based analysis of the immunocompetent serological response to Lomentospora prolificans. J Proteome Res 15(2):595–607
40. Rappuoli R, Covacci A (2003) Reverse vaccinology and genomics. Science 302:602
41. Rodríguez-Ortega MJ, Norais N, Bensi G, Liberatori S, Capo S, Mora M, Scarselli M, Doro F, Ferrari G, Garaguso I, Maggi T, Neumann A, Covre A, Telford JL, Grandi G (2006) Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat Biotechnol 24:191–197
42. Santos AR, Carneiro A, Gala-García A, Pinto A, Barh D, Barbosa E, Aburjaile F, Dorella F, Rocha F, Guimarães L, Zurita-Turk M, Ramos R, Almeida S, Soares S, Pereira U, Abreu VC, Silva A, Miyoshi A, Azevedo V (2012) The Corynebacterium pseudotuberculosis in silico predicted pan-exoproteome. BMC Genom 13(Suppl 5):S6
43. Seib KL, Zhao X, Rappuoli R (2012) Developing vaccines in the era of genomics: a decade of reverse vaccinology. Clin Microbiol Infect 5:109–116
44. Sengupta N, Alam SI, Kumar B, Kumar RB, Gautam V, Kumar S, Singh L (2010) Comparative proteomic analysis of extracellular proteins of Clostridium perfringens type A and type C strains. Infect Immun 78:3957–3968
45. Snider CA, Voss BJ, McDonald WH, Cover TL (2016) Growth phase-dependent composition of the Helicobacter pylori exoproteome. J Proteom 130:94–107
46. Testa JS, Shetty V, Hafner J, Nickens Z, Kamal S, Sinnathamby G, Philip R (2012) MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response. PLoS One 7(11):e48484. doi:10.1371/journal.pone.0048484
47. Trost M, Wehmhöner D, Kärst U, Dieterich G, Wehland J, Jänsch L (2005) Comparative proteome analysis of secretory proteins from pathogenic and non-pathogenic Listeria species. Proteomics 5:1544–1557
48. Tsolakos N, Brookes C, Taylor S, Gorringe A, Tang CM, Feavers IM, Wheeler JX (2014) Identification of vaccine antigens using integrated proteomic analyses of surface immunogens from serogroup B Neisseria meningitidis. J Proteom 101:63–76
49. Vivona S, Bernante F, Filippini F (2006) NERVE: new enhanced reverse vaccinology environment. BMC Biotechnol 6:35
50. Walters MS, Mobley HL (2009) Identification of uropathogenic Escherichia coli surface proteins by shotgun proteomics. J Microbiol Methods 78(2):131–135
51. Walters MS, Mobley HL (2010) Bacterial proteomics and identification of potential vaccine targets. Expert Rev Proteom 7:181–184
52. Walz A, Mujer CV, Connolly JP, Alefantis T, Chafin R, Dake C, Whittington J, Kumar SP, Khan AS, DelVecchio VG (2007) Bacillus anthracis secretome time course under host-simulated conditions and identification of immunogenic proteins. Proteome Sci 5:11
53. Wen YT, Tsou CC, Kuo HT, Wang JS, Wu JJ, Liao PC (2011) Differential secretomics of Streptococcus pyogenes reveals a novel peroxide regulator (PerR)-regulated extracellular virulence factor mitogen factor 3 (MF3). Mol Cell Proteom 10(M110):007013
54. Wöhlbrand L, Trautwein K, Rabus R (2013) Proteomic tools for environmental microbiology-a roadmap from sample preparation to protein identification and quantification. Proteomics 13:2700–2730
55. Wright A, Wait R, Begum S, Crossett B, Nagy J, Brown K, Fairweather N (2005) Proteomic analysis of cell surface proteins from Clostridium difficile. Proteomics 5:2443–2452
56. Yang HL, Zhu YZ, Qin JH, He P, Jiang XC, Zhao GP, Guo XK (2006) In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans. BMC Genom 16(7):293
57. Yang Y, Wang L, Yin J, Wang X, Cheng S, Lang X, Wang X, Qu H, Sun C, Wang J, Zhang R (2011) Immunoproteomic analysis of Brucella melitensis and identification of a new immunogenic candidate protein for the development of brucellosis subunit vaccine. Mol Immunol 49(1–2):175–184
58. Zeng L, Zhang Y, Zhu Y, Yin H, Zhuang X, Zhu W, Guo X, Qin J (2013) Extracellular proteome analysis of Leptospira interrogans serovar Lai. OMICS 17(10):527–535
59. Zhao Z, Yan F, Ji W, Luo D, Liu X, Xing L, Duan Y, Yang P, Shi X, Lu Z, Wang X (2011) Identification of immunoreactive proteins of Brucella melitensis by immunoproteomics. Sci China Life Sci 54(9):880–887
60. Zielke RA, Wierzbicki IH, Baarda BI, Gafken PR, Soge OO, Holmes KK, Jerse AE, Unemo M, Sikora AE (2016) Proteomics-driven antigen discovery for development of vaccines against gonorrhea. Mol Cell Proteom 15(7):2338–2355